View more job listings or post a job
Simcere of America Inc. VP of Boston Innovation Center
Simcere Pharma Group 制剂研发总监或以上 Drug Formulation Director  
Simcere of America Inc. Job Title: Senior Director, Toxicology    
Simcere of America Inc. Associate Director/Director, Regulatory Affairs  
Simcere of America Inc. Director of Business Development
Simcere of America Inc. Job Title: Business Development Intern  
Charles River Laboratories Research Associate
Genomics Institute of the Novartis Research Foundation Senior Investigator (Associate Director) in DMPK
Pliant Therapeutics, Inc. Description: Pliant Therapeutics is an early stage biopharmaceutical company focused on the discovery and development of novel therapies for fibrotic diseases. Founded by Third Rock Ventures with world-renowned academic th
Post a job


Drug Metabolism and Metabolite Identification: Strategies, Techniques, and Case Studies

Speakers: S. Cyrus Khojasteh, PhD (Genentech), Bill Fitch, PhD (PosNeg Consulting), Shichang Miao, PhD (ChemoCentryx), Ryan Takahashi, PhD (Genentech), Raju Subramanian, PhD (Gilead), Shuguang Ma, PhD (Genentech)
Organizers: Shuguang Ma, Shichang Miao
Date: 2/22/2018
Time: 8:30-17:00
Registration fee (USD): Regular: $195; Academic: $125; For unemployed or students: $30; For vendor-show rep: $35; For major-sponsor rep (incl lunch): $0;
Location: SF Bay Area: Foster City Crowne Plaza
Major Sponsor: (2)Molecular Discovery; WuXi AppTec
Vendor show vendors registered to date: (20)Absorption Systems; Alturas Analytics; BioDuro; Bruker; CMIC, Inc.; Covance; Cytovier LLC; Hypha Discovery; Intertek; MicroConstants; Pharmaron; PHARMout Laboratories; PPD; QPS; Quotient Sciences; SCIEX; Sekisui XenoTech, LLC; Seventh Wave; Waters Corporation; Zef Scientific
Registration deadline:2/15/2018  (it will close sooner if the seating cap is reached)

About the Topic

Metabolism plays a key role in the elimination of drugs and their pharmacokinetics. Identification of the metabolites is a major component in drug metabolism studies and is critical for both drug discovery and drug development.  It requires careful strategic planning, utilization of modern analytical techniques in LCMS and NMR, and in-depth data analysis and interpretation. Deep understanding of the fundamentals of drug metabolism and organic chemistry is essential for a successful metabolite ID scientist.  This workshop will discuss drug metabolizing enzymes, state-of-the-art techniques for generating, detecting, and identifying metabolites, data mining tools and MS/MS spectral interpretation, stage-based approaches for metabolite identification in drug discovery and development, and strategies for metabolites-in-safety testing.

This workshop will cover the following topics:

  • Overview of drug metabolism and drug metabolizing enzymes
  • Metabolite identification overview and metabolite detection techniques
  • Metabolite structure identification by MS/MS and NMR
  • General strategies for metabolite identification in drug discovery and development
  • Metabolite generation techniques
  • First-in-human metabolite profiling and metabolites-in-safety testing strategies

About the Speakers

Dr. S Cyrus Khojasteh leads the Biotransformation Group at Genentech (South San Francisco), and was at Pfizer (Groton, CT) prior to 2000. His research focuses on the mechanisms of biotransformation in drug discovery and development with a particular interest in metabolism mediated by cytochrome P450 and non-cytochrome P450 enzymes. Cyrus received his B.S. from the University of California at Berkeley and his Ph.D. in Medicinal Chemistry from the University of Washington under the direction of Dr. Sidney D. Nelson.

Dr. William Fitch consults in drug metabolism, bioanalysis and mass spectrometry at Stanford University and for local pharmaceutical firms. He received his BS at University of Michigan and his PhD at Stanford. He did postdoctoral stints in biosynthetic chemistry at Yale, synthetic chemistry at Syntex and clinical mass spectrometry at Stanford. His 31 year industrial career focused on applications of mass spectrometry in environmental analysis, agricultural chemical discovery, combinatorial chemistry and pharmaceutical discovery. Dr. Fitch has published 69 papers, articles and book chapters.

Dr. Shichang Miao is currently Vice President, Preclinical Development & Clinical DMPK at ChemoCentryx. Previously, he was a director in the pharmacokinetics and drug metabolism department at Amgen South San Francisco. He worked at Tularik Inc. from 1994 through 2004 (most recently as Associate Director, Analytical Chemistry and Drug Metabolism) until Tularik's acquisition by Amgen. He is the founder and president of Pharmaceutical & BioScience Society International. He holds a PhD in organic chemistry / natural products chemistry from the University of British Columbia (Vancouver, Canada) and conducted his postdoctoral research in biochemistry and protein mass spectrometry.

Dr. Ryan Takahashi is a Scientist in DMPK at Genentech, Inc. In this role, he is responsible for supporting small molecule development programs by investigating and advising on metabolism-related concerns. This has led to research focused on characterizing mechanisms and enzymology of drug biotransformation pathways. He received his PhD. from the Faculty of Pharmaceutical Sciences at the University of British Columbia, where he studied roles for aldo-keto reductase enzymes in anthracycline and androgen metabolism under the supervision of Drs. Wayne Riggs and Ronald Reid.

Dr. Raju Subramanian is a Director and head of pharmacokinetics in the department of Drug Metabolism and Pharmacokinetics at Gilead Sciences. He was a Scientific Director at Amgen in the department of Pharmacokinetics and Drug Metabolism in Thousand Oaks CA and was a Research Fellow at Merck in West Point, PA. He received his Ph. D. in Physical Chemistry from State University of New York at Stony Brook, and had post doctoral training at Department of Physics, College of William and Mary and at Beckman Institute, University of Illinois Urbana-Champaign.

Dr. Shuguang Ma is currently a Principal Scientist in DMPK at Genentech Inc. Previously he was a Senior Principal Scientist at Schering-Plough (now Merck) and a Senior Scientist at Amgen. He received his Ph.D. in Analytical Chemistry from Purdue University under the direction of Professor R. Graham Cooks. He has authored 55 research articles in the peer-reviewed journals and three book chapters, covering broad area of mass spectrometry and its applications.

2018-11-16, Hybrid LC-MS for Protein therapeutics and biomarkers: Recent developments in characterization and quantification
2018-12-04, Challenges in Peptide Drug Discovery & Development: Biology, Chemistry, PK, Delivery, Regulatory and Beyond
2019-02-07, Covalent Inhibitor Drug Discovery & Development: Biology, Chemistry, PK, Safety and Case Studies (Jointly with Bay Area PKPD Network)
2019-03-07, Promising therapeutic approaches and transnational medicine from SPARK: an academic-industry collaboration to advance novel therapeutics (A Joint Symposium by PBSS and Stanford SPARK Program)
2019-03-11, Clinical Trials Essentials: An Intensive One-Week Course (register for the full week or half day sessions)
©Pharmaceutical & BioScience Society, International; Last Modified: 11/13/2018; Visited: 1283; Admin Logon
Ads (in random order)
Submit a Text Ad
($200 for 2 months)

Clinverse Inc. A global technology company solely focused on automating the financial management of clinical trials.
Nuventra Pharma Sciences With a background in clinical pharmacology and PK/PD, Nuventra enables our clients to make better strategic decisions.
Pharm-Olam International Pharm-Olam is a midsize CRO offering a wide range of Phase I-IV comprehensive, clinical research services to the pharma, biotech & device industries.
Charles River 2nd Annual Viral Summit The 2-day summit unites industry experts in an interactive setting to share updates and discuss trends in viral safety and viral clearance.
Simulations Plus GastroPlus™ PBPK modeling workshops scheduled around the globe to train scientists on the new guidance documents from the FDA and EMA. Register today!
Solid Form Solutions Ltd Solid Form Solutions Ltd CRO providing Solid State Crystallization and Analytical Testing Services to the pharma/biotech industries.
Simulations Plus From the developers of GastroPlus™ comes PKPlus™. NCA & compartmental PK modeling for regulatory submissions. True "PlugNPlay" PK.
MicroConstants MicroConstants is a GLP-compliant Contract Research Organization focused on performing regulated bioanalysis, drug metabolism and PK analysis.
UC Davis UC Davis Liquid Chromatography/Mass Spectrometry and Confirmation Supervisor Apply Online: UC Davis i
Pharmaron Our Vision: To become the world-leading small-molecule life science R&D service company, supporting our partners from discovery to commercialization
INTERTEK PHARMACEUTICAL SERVICES Intertek, a bioanalytical CRO (drugs, biologics, proteins, ADCs, biosimilar, generics, peptide, biomarker, immunogenicity, ADA, Nab) in San Diego CA
Simulations Plus ADMET Predictor™ 9 - ADMET property estimation, HTPK Simulation, SAR elucidation, and QSAR model building software.
Origin Bioanalytical Laboratory A contract research organization for bioanalytical LC-MS/MS analysis specializing in ocular tissues/fluids located Rancho Cordova, CA
Reaction Biology Corporation (RBC) RBC provides kinase & epigenetic assays and proteins for early-stage programs. Contact:
Hypha Discovery Specialists in provision of drug metabolites at mg-g scale, including CYP/Non-CYP metabolites and conjugates such as glucuronides/sulfates.
S-Matrix Fusion QbD® Software – Analytical Method Development & Validation, Formulation & Process R&D. Works with ChemStation, Chromeleon, and Empower.
Protein Characterization Seminar hosted by Charles River Join us in San Diego on September 15, 2017 to discuss the analytical methods used to detect process residuals and determine biosimilarity.
Zef Scientific California’s premier multi-vendor LC-MS/MS engineering firm with highest level of services & rapid onsite response on all major brands & models.
Avecia Pharma Services Nitto Avecia Pharma provides GMP contract development and parenteral manufacturing services to the pharma/biotech industries. Visit our Irvine labs!
Pacific BioLabs Offers toxicology,microbiology,analytical and bioanalytical services with a combination of technical expertise & rigorous quality systems.
Simulations Plus From sketching chemical structures, all the way through regulatory filings, Simulations Plus consulting experts can help. Over 20 years of experience!
BIOTECH WEEK BOSTON - Sept. 4-7 Join us at Biotech Week Boston - Where Big Science and Bright Minds Meet. Sept. 4-7, 2018 at Hynes Convention Center.
Sirius Analytical Services and Automated Instruments for pKa, log P/D, solubility, dissolution. New Scissor instrument for sub-cutaneous injection site simulation.
PHARMA INVENTOR Vancouver based Canadian Custom Synthesis Services Company, Offers Inventive & Cost-Effective Chemical Synthesis Services to Life Sciences Industries.
Nektar Therapeutics Sr. Scientist - Bioanalytical Contributes to the development, validation, and implementation of ligand-binding assays. PhD and 5 years exp.
Submit a Text Ad